• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by Alphabet Inc.

    6/18/25 4:28:42 PM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology
    Get the next $GOOGL alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0001534753
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    ALPHABET INC.
    SEC File Number
    001-37580
    Address of Issuer
    1600 Amphitheatre Parkway
    Mountain View
    CALIFORNIA
    94043
    Phone
    6502530000
    Name of Person for Whose Account the Securities are To Be Sold
    SUNDAR PICHAI
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Director
    Relationship to Issuer
    Officer

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Common Class C
    Morgan Stanley Smith Barney LLC Executive Financial Services
    1 New York Plaza
    8th Floor
    New York � NY � 10004
    325005759975.00545900000006/18/2025
    NASDAQ


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Common Class C01/12/2022Restricted Stock UnitsIssuerCheckbox not checked3250001/12/2022N/A

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Name and Address of SellerTitle of Securities SoldDate of SaleAmount of Securities SoldGross Proceeds
    10b5-1 Sales for PICHAI FAMILY FOUNDATION
    1600 Amphitheatre Parkway
    Mountain View � CA � 94043
    Common Class C06/04/20254000674870.00
    10b5-1 Sales for SUNDAR PICHAI
    1600 Amphitheatre Parkway
    Mountain View � CA � 94043
    Common Class C06/04/2025325005483234.25
    10b5-1 Sales for PICHAI FAMILY FOUNDATION
    1600 Amphitheatre Parkway
    Mountain View � CA � 94043
    Common Class C05/21/20254000683184.80
    10b5-1 Sales for SUNDAR PICHAI
    1600 Amphitheatre Parkway
    Mountain View � CA � 94043
    Common Class C05/21/2025325005553297.75
    10b5-1 Sales for PICHAI FAMILY FOUNDATION
    1600 Amphitheatre Parkway
    Mountain View � CA � 94043
    Common Class C05/07/20254000624606.00
    10b5-1 Sales for SUNDAR PICHAI
    1600 Amphitheatre Parkway
    Mountain View � CA � 94043
    Common Class C05/07/2025325005066763.00
    10b5-1 Sales for PICHAI FAMILY FOUNDATION
    1600 Amphitheatre Parkway
    Mountain View � CA � 94043
    Common Class C04/16/20254000624484.40
    10b5-1 Sales for SUNDAR PICHAI
    1600 Amphitheatre Parkway
    Mountain View � CA � 94043
    Common Class C04/16/2025325005075148.00
    10b5-1 Sales for PICHAI FAMILY FOUNDATION
    1600 Amphitheatre Parkway
    Mountain View � CA � 94043
    Common Class C04/02/20254000634102.80
    10b5-1 Sales for SUNDAR PICHAI
    1600 Amphitheatre Parkway
    Mountain View � CA � 94043
    Common Class C04/02/2025325005153135.00

    144: Remarks and Signature

    Remarks
    The securities to be sold were acquired upon the vesting of restricted stock units during the period of 01/12/2022 through 03/25/2024
    Date of Notice
    06/18/2025
    Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1
    12/02/2024

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    /s/ Sundar Pichai

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $GOOGL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GOOGL

    DatePrice TargetRatingAnalyst
    4/25/2025$185.00 → $195.00Overweight
    KeyBanc Capital Markets
    4/25/2025$185.00 → $200.00Buy
    BofA Securities
    4/25/2025$165.00 → $185.00Mkt Perform
    Bernstein
    4/25/2025$185.00 → $195.00Overweight
    Piper Sandler
    4/25/2025$167.00 → $175.00Equal Weight
    Wells Fargo
    4/25/2025$205.00 → $189.00Buy
    Rosenblatt
    4/25/2025$173.00 → $186.00Neutral
    UBS
    4/25/2025$225.00 → $220.00Positive
    Susquehanna
    More analyst ratings

    $GOOGL
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Smart Healthcare Is Taking Over. Here's Where the Money's Headed

      Issued on behalf of Avant Technologies Inc.Equity Insider News Commentary VANCOUVER, BC, June 10, 2025 /PRNewswire/ -- Both politicians and leaders in academia are touting the AI revolution empowering the frontline of what's dubbed Smart Healthcare. In a recent write-up in Forbes, Prof. Nicos Savva of the London Business School cited recent speeches from former British Prime Minister Tony Blair, who insists that the UK needs to embrace a future with AI doctors and nurses, or risk being left behind. A new report from Wolters Kluwer has experts calling for more clarity around its use, adoption, and business strategy, because most healthcare organizations aren't currently ready to use GenAI too

      6/10/25 11:13:00 AM ET
      $AMZN
      $GOOG
      $GOOGL
      $OMDA
      Catalog/Specialty Distribution
      Consumer Discretionary
      Computer Software: Programming Data Processing
      Technology
    • Circus SE Successfully Acquires Agentic AI Company FullyAI

      FullyAI becomes the core AI intelligence layer powering operational guidance, prediction models, and personalized AI experiences across Circus' robotics and software stack Technology to leverage billions of data points from Circus robotic systems to scale a global intelligence network for its autonomous food systems and nutrition patterns FullyAI's team becomes part of Circus, including new leadership in AI and growth to scale the next phase of intelligent food autonomy Circus SE (XETRA: CA1), a global technology leader in AI-robotics for the food service industry, today announces the successful acquisition of agentic AI company FullyAI, marking a major milestone in its mission to bu

      5/21/25 4:18:00 AM ET
      $GOOGL
      $MCD
      $META
      $TSLA
      Computer Software: Programming Data Processing
      Technology
      Restaurants
      Consumer Discretionary
    • New Advances in Healthcare AI Could Unlock Billions in Market Opportunity

      USA News Group News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, April 29, 2025 /CNW/ -- Artificial intelligence is making deeper inroads into western healthcare, targeting the slow grind of authorizations and paperwork that bog down patient care. Despite Bill Gates' prophecy about AI replacing doctors, the real push today is about supercharging physicians, not sidelining them. Recent moves by players such as like Avant Technologies, Inc. (OTCQB:AVAI), Amesite Inc. (NASDAQ:AMST), Oracle Corporation (NYSE:ORCL), Clover Health Investments, Corp. (NASDAQ:CLOV), and Alphabet Inc. (NASDAQ:GOOG, GOOGL)) are signaling just how fast this transformation is taking hold.

      4/29/25 11:29:00 AM ET
      $AMST
      $CLOV
      $GOOG
      $GOOGL
      Computer Software: Prepackaged Software
      Technology
      Medical Specialities
      Health Care

    $GOOGL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Arnold Frances was granted 5 units of Class C Google Stock Units, increasing direct ownership by 75% to 1,513 units (SEC Form 4)

      4 - Alphabet Inc. (0001652044) (Issuer)

      6/18/25 7:03:46 PM ET
      $GOOGL
      Computer Software: Programming Data Processing
      Technology
    • Director Washington Robin L was granted 5 units of Class C Google Stock Units, increasing direct ownership by 75% to 1,513 units (SEC Form 4)

      4 - Alphabet Inc. (0001652044) (Issuer)

      6/18/25 6:59:13 PM ET
      $GOOGL
      Computer Software: Programming Data Processing
      Technology
    • Director Shriram Kavitark Ram was granted 5 units of Class C Google Stock Units, increasing direct ownership by 75% to 1,513 units (SEC Form 4)

      4 - Alphabet Inc. (0001652044) (Issuer)

      6/18/25 6:54:32 PM ET
      $GOOGL
      Computer Software: Programming Data Processing
      Technology